In children with sickle cell anemia, a study focused on changes in the plasma proteome after treatment indicates that Hpx correlates with higher levels of fetal hemoglobin, suggesting its potential utility in monitoring therapeutic responses [49]. The gene discussed is HPX; the disease is sickle cell disease.